Скачать с ютуб What's New in PH: Guidelines and Evidence for Improved Clinical Care в хорошем качестве

What's New in PH: Guidelines and Evidence for Improved Clinical Care

Real-World PH Registries: What do they tell us? AMA/ANCC/ACPE Activity This AMA/ANCC/ACPE activity features a recorded discussion among three leading pulmonary hypertension (PH) experts and is designed to keep healthcare professionals on top of the most recent clinical findings. Updated guidelines from the European Society of Cardiology and European Respiratory Society (ESC/ERS) were recently released providing the latest evidence for the care of patients with pulmonary hypertension (PH). This research presented at ERS along with CHEST 2022 also provide clinical implications of the latest evidence for the care of patients with pulmonary hypertension (PH). In addition, this activity will discuss the array of registry databases, what information has been yielded about the demographic factors, treatment, and survival of patients, as well as their limitations, which provides real-world evidence that informs clinical practice and health policy. FACULTY Ronald Oudiz, MD, FACP, FACC, FCCP Professor of Medicine David Geffen School of Medicine at UCLA Interim Chief, Division of Cardiology Director, Liu Center for Pulmonary Hypertension Ludquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Marc Humbert, MD, PhD Professor of Respiratory Medicine Paris-Saclay University​ Director of the French Reference Centre for Pulmonary Hypertension Hospital Bicêtre (Assistance Publique Hôpitaux de Paris) Marion Delcroix, MD, PhD Professor of Medicine and of Respiratory Physiology University of Leuven and Kortrijk Head of Pulmonary Vascular Disease Program and Intermediate Respiratory Care Unit University Hospitals of Leuven Review the activity at bit.ly/3BdcUDk and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation. This activity is jointly provided by the University of Nebraska Medical Center, Duquesne University School of Pharmacy and Practice Point Communications Supported by independent educational grants from United Therapeutics Corporation, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson